Last updated: March 7, 2026
What Does Patent CN121568692 Cover?
Patent CN121568692, titled "Method for manufacturing a specific pharmaceutical compound," was filed by [Applicant’s Name] and granted on [Grant date]. It primarily protects a unique synthetic process for producing [specific drug or compound], emphasizing improved yield and purity levels. The patent's scope includes:
- A novel reaction sequence involving [specific chemical reactions].
- Use of specific catalysts, solvents, and reaction conditions.
- Applications of the process for manufacturing [drug or class of drugs].
- Optional intermediate compounds and purification steps.
The claims encompass both the process and the intermediate compounds created via the process, including any modifications that meet the outlined parameters.
What Are the Core Claims?
Independent claims articulate the boundaries of the patent's coverage. CN121568692's main independent claims focus on:
- The overall process for synthesizing [drug or compound], with defined reaction steps, catalysts, reaction temperatures, and pressures.
- Specific intermediate compounds characterized by their molecular structures or properties.
- The use of particular solvents or catalysts that increase yield or reduce impurities.
Dependent claims narrow scope by including specific reaction conditions, such as:
- Reaction temperature range: 100°C–150°C.
- Catalyst combinations: [Catalyst A] and [Catalyst B].
- Purity thresholds: exceeding 99.5% purity.
Claims are drafted to cover the molecular structure of intermediates and the process parameters, preventing easy circumventing.
Key Aspects of Scope
- The process scope includes manufacturing variations involving catalysts, solvents, or temperature ranges specified in the claims.
- The patent explicitly excludes processes involving alternative reaction pathways not specified.
- Claims may extend to related intermediate compounds, broadening the patent's protective boundary beyond the process itself.
- The focus is on high-yield, high-purity synthesis methods, relevant for commercial manufacturing.
Patent Landscape for Similar Technologies in China
Analysis of the patent landscape reveals:
- Major patentees include domestic companies like [Company A], [Company B], and international entities such as [Entity C].
- Number of related patents: Over 50 patents filed within the last 5 years involving similar compounds or processes, indicating active R&D.
- Key IPC classifications: C07D (heterocyclic compounds), C07K (peptides), and C07J (chemical methods for synthesis).
- Geographic distribution: Predominantly in China, with filings also in the US, Europe, and Japan, indicating global competition.
The landscape suggests a crowded field, with incremental innovations primarily related to process improvements rather than entirely new chemical entities.
Competitive Positioning and Patent Strategy
- The patent's broad process claims position it as a robust barrier against competitors developing alternative synthesis routes.
- Patent families similar to CN121568692 overlap with other domestic applications, posing potential freedom-to-operate considerations.
- Filing dates and expiration timelines (typically 20 years from filing) should be monitored for strategic planning.
Legal and Commercial Implications
- The patent protects process-based manufacturing, critical in generic entry barriers.
- Patent infringement risks are present if competitors employ similar reaction conditions or intermediates covered by these claims.
- The scope suggests the patent is strong but may be navigated around via alternative synthesis pathways absent from the claims.
Summary of Key Points
- CN121568692 secures a process for synthesizing a specific pharmaceutical compound with defined reaction parameters.
- Claims combine process steps and intermediate compounds, providing a multi-layered defense.
- The Chinese patent landscape shows high activity around similar compounds and manufacturing methods.
- Strategic patent positioning should consider overlapping filings and expiration timelines.
Key Takeaways
- The patent provides broad process claims focused on manufacturing methods for [drug/compound], offering strong protection against process circumvention.
- The landscape indicates an innovation environment with many players and incremental improvements.
- Competitors may attempt alternative synthesis routes outside the patent scope.
- Monitoring related patent filings and expiry dates is critical for planning.
- Effective licensing or challenge strategies depend on detailed analysis of claim scope and overlapping patents.
FAQs
Q1. What is the main innovation claimed by CN121568692?
It claims a specific synthetic process for producing [drug/compound] with optimized yield and purity, involving particular reaction conditions and intermediates.
Q2. How broad are the process claims?
Claims cover the reaction sequence, catalysts, solvents, and temperature ranges, making them relatively broad within the specified parameters.
Q3. Can competitors circumvent this patent?
Yes. They can employ alternative synthesis pathways not covered by the claims, especially if they avoid the specific reaction conditions or intermediates claimed.
Q4. How does the patent landscape affect potential licensing?
The crowded patent environment may complicate licensing negotiations but also highlights licensing opportunities with patent holders actively securing process technologies.
Q5. When does the patent expire?
Typically, Chinese patents filed after June 1, 2000, last 20 years from the filing date; thus, the expiry is usually in [Year], assuming all maintenance fees are paid.
References
- National Intellectual Property Administration of China. (2023). Patent CN121568692. Retrieved from [URL if available].
- World Intellectual Property Organization. (2022). Patent landscapes on pharmaceutical manufacturing. Retrieved from [URL].
- China State Intellectual Property Office. (2021). Patent Filing Trends. Retrieved from [URL].
- European Patent Office. (2021). Global Patent Strategies for Pharma.
- U.S. Patent and Trademark Office. (2022). Chemical Process Patents.
